コンテンツメニュー

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus : A combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study

Cardiovascular Diabetology Volume 13 Issue 1 Page 65-
published_at 2014-03-28
Title
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus : A combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Creators Kaku Kohei
Creators Watada Hirotaka
Creators Iwamoto Yasuhiko
Creators Utsunomiya Kazunori
Creators Terauchi Yasuo
Creators Tobe Kazuyuki
Creators Tanizawa Yukio
Creators Araki Eiichi
Creators Ueda Masamichi
Creators Suganami Hideki
Creators Watanabe Daisuke
Creator Keywords
SGLT2 inhibitor Tofogliflozin CSG452 RG7201 HbA_1c Body weight
Languages eng
Resource Type journal article
Publishers BioMed Central
Date Issued 2014-03-28
File Version Not Applicable (or Unknown)
Access Rights metadata only access
Relations
[ISSN]1475-2840
[NCID]AA12050431
[PMID]info:pmid/24678906
info:doi/10.1186/1475-2840-13-65
[isVersionOf] [URI]http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=107&action=archive
Schools 大学院医学系研究科(医学)